CompletedNot Applicable

Alleviating Geriatric Inpatients' Medication-related Iatrogenesis

United States60 participantsStarted 2021-09-15

Plain-language summary

This study will evaluate the MedWise Risk Score™ (MWRS™), a holistic approach to quantifying the risk of a patient's medication regimen. High risk patients will be identified at hospital discharge. Targeted interventions will be made to reduce their MWRS™ with a 30-day follow up. The hypothesis being tested is that a reduction in MWRS™ will lead to reduced 30-day readmission.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hospital admission for at least 48 hours * Prescribed at least 5 medications at hospital discharge * Baseline medication risk score of 20 or more Exclusion Criteria: * Reside greater than 25 miles from the index facility * Discharge to hospice * Discharge against medical advice * Patient expiration during initial hospitalization

What they're measuring

Number of individuals with an emergency department visit or hospital readmission

Timeframe: 30 days after hospital discharge

Trial details

NCT IDNCT05017948

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-01

View on ClinicalTrials.gov More Iatrogenic Disease trials